Assignee profile:

OPKO Pharmaceuticals, LLC

City:

Miami, Florida

Country:

United States

Published Applications:

11

Last publication date:

2020-12-24

Patent Grants:

9

Last grant date:

2022-01-04

Top Inventors for applications by OPKO Pharmaceuticals, LLC

These are the the leading inventors for applications assigned to OPKO Pharmaceuticals, LLC:

Recent patent applications by OPKO Pharmaceuticals, LLC

OPKO Pharmaceuticals, LLC based in Miami, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-12-24 βœ… Patent 11,215,618 granted on 2022-01-04
US20200400676A1
Physics

Articles and methods directed to personalized therapy of cancer

#2 | 2020-11-19
US20200363420A1
Physics

ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER

#3 | 2020-08-27
US20200271657A1
Physics

ARTICLES AND METHODS DIRECTED TO PERSONALIZED THERAPY OF CANCER

#4 | 2020-05-28 βœ… Patent 11,712,419 granted on 2023-08-01
US20200163877A1
Human necessities

Liposome formulations

#5 | 2019-10-24 βœ… Patent 11,458,199 granted on 2022-10-04
US20190321467A1
Human necessities

Liposome formulations

#6 | 2019-06-20 βœ… Patent 10,829,509 granted on 2020-11-10
US20190185503A1
Chemistry; metallurgy

Pure heptasulfated disaccharides having improved oral bioavailability

#7 | 2015-08-13 βœ… Patent 10,548,841 granted on 2020-02-04
US20150224055A1
Human necessities

Liposome formulations

#8 | 2014-05-29 βœ… Patent 9,458,199 granted on 2016-10-04
US20140147455A1
Chemistry; metallurgy

Antigen surrogates in autoimmune disease

#9 | 2012-11-01 βœ… Patent 8,946,180 granted on 2015-02-03
US20120277288A1
Chemistry; metallurgy

Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification

#10 | 2012-08-30 βœ… Patent 8,603,756 granted on 2013-12-10
US20120219574A1
Human necessities

Antigen surrogates in autoimmune disease

#11 | 2010-06-17 βœ… Patent 8,470,792 granted on 2013-06-25
US20100151007A1
Chemistry; metallurgy

Compositions and methods for selective inhibition of VEGF

Also check out OPKO Pharmaceuticals, LLC's (Miami, United States) applicant profile with 5 patent applications submitted.

AssigneeID:

66240 ⎘